These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Semiologic value of LDL cholesterol and apolipoprotein B in risk of atherosclerosis]. Frey J; Couderc R Ann Biol Clin (Paris); 1998; 56(5):517-20. PubMed ID: 9769517 [No Abstract] [Full Text] [Related]
8. [Abetalipoproteinemia in a Polish family]. Kaciński M; Grzenda-Adamek Z; Miezyński W; Kaczmarski F; Miszczuk-Jamska B Pediatr Pol; 1989; 64(8-9):551-8. PubMed ID: 2642215 [No Abstract] [Full Text] [Related]
9. Which lipid measures are prognostic indicators of cardiovascular disease in women? Oettgen P Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):190-1. PubMed ID: 16932280 [No Abstract] [Full Text] [Related]
10. [The use of apolipoprotein B in clinical practice to determine the risk for atherosclerosis]. Cabezas Castro M; Liem A Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1445-8. PubMed ID: 12908345 [TBL] [Abstract][Full Text] [Related]
12. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study. Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285 [TBL] [Abstract][Full Text] [Related]
13. Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B. Stein EA; Sniderman A; Laskarzewski P Am J Cardiol; 2005 Nov; 96(9A):36K-43K; discussion 34K-35K. PubMed ID: 16291013 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B (apoB) more closely related to subclinical atherosclerosis than non-HDL cholesterol and LDL cholesterol. Walldius G J Intern Med; 2010 Dec; 268(6):549-51. PubMed ID: 21091807 [No Abstract] [Full Text] [Related]
15. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118 [TBL] [Abstract][Full Text] [Related]
17. Apolipoproteins as markers and managers of coronary risk. Chan DC; Watts GF QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986 [TBL] [Abstract][Full Text] [Related]
18. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks]. Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206 [TBL] [Abstract][Full Text] [Related]
19. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained? Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518 [TBL] [Abstract][Full Text] [Related]
20. [Measurement of apolipoproteins is better than routinely measured traditional lipids]. Kallner A; Estonius M Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202 [No Abstract] [Full Text] [Related] [Next] [New Search]